These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11602888

  • 1. A single center experience with extrahepatic cholangiocarcinomas.
    Johnson SR, Kelly BS, Pennington LJ, Hanto DW.
    Surgery; 2001 Oct; 130(4):584-90; discussion 590-2. PubMed ID: 11602888
    [Abstract] [Full Text] [Related]

  • 2. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.
    Hernandez J, Cowgill SM, Al-Saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A.
    Ann Surg Oncol; 2008 Mar; 15(3):807-14. PubMed ID: 18181000
    [Abstract] [Full Text] [Related]

  • 3. Management of hilar bile duct carcinoma.
    Bathe OF, Pacheco JT, Ossi PB, Hamilton KL, Franceschi D, Sleeman D, Levi JU, Livingstone AS.
    Hepatogastroenterology; 2001 Mar; 48(41):1289-94. PubMed ID: 11677948
    [Abstract] [Full Text] [Related]

  • 4. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K.
    Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
    Shi QF, Liang TB, Qin YS, Wang WL, Shen Y, Zhang M, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 15; 6(6):622-6. PubMed ID: 18086629
    [Abstract] [Full Text] [Related]

  • 6. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y.
    Ann Surg; 2007 Dec 15; 246(6):1052-7. PubMed ID: 18043110
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H.
    Cancer; 2003 Jun 01; 97(11):2783-90. PubMed ID: 12767091
    [Abstract] [Full Text] [Related]

  • 8. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM, Sachs D, Bloomston M, Carey LC, Karl RC, Murr MM, Rosemurgy AS.
    Am Surg; 2001 Sep 01; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [Abstract] [Full Text] [Related]

  • 9. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug 01; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]

  • 10. Surgical management of cholangiocarcinoma.
    Jarnagin WR, Shoup M.
    Semin Liver Dis; 2004 May 01; 24(2):189-99. PubMed ID: 15192791
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G, Di Benedetto F, Cautero N, Masetti M, Mercantini P, Corigliano N, Nigri G, Lauro A, Ercolani G, Del Gaudio M, De Ruvo N, Pinna AD.
    Chir Ital; 2004 May 01; 56(6):749-59. PubMed ID: 15771027
    [Abstract] [Full Text] [Related]

  • 12. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS.
    Am Surg; 2004 Sep 01; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [Abstract] [Full Text] [Related]

  • 13. [Criteria for the resectability of malignant extrahepatic bile duct tumours].
    Kissenkoetter S, Witzigmann H.
    Zentralbl Chir; 2012 Feb 01; 137(1):32-7. PubMed ID: 22344835
    [Abstract] [Full Text] [Related]

  • 14. Prognosis and treatment of bile duct carcinoma.
    Chung C, Bautista N, O'Connell TX.
    Am Surg; 1998 Oct 01; 64(10):921-5. PubMed ID: 9764692
    [Abstract] [Full Text] [Related]

  • 15. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2787-94. PubMed ID: 18685896
    [Abstract] [Full Text] [Related]

  • 16. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):189-98. PubMed ID: 20971573
    [Abstract] [Full Text] [Related]

  • 17. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR.
    Am J Clin Oncol; 2003 Aug 01; 26(4):422-8. PubMed ID: 12902899
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.
    Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Chen P, Busuttil RW.
    Liver Transpl; 2001 Dec 01; 7(12):1023-33. PubMed ID: 11753904
    [Abstract] [Full Text] [Related]

  • 19. Aggressive surgical resection for hilar cholangiocarcinoma.
    Lai EC, Lau WY.
    ANZ J Surg; 2005 Nov 01; 75(11):981-5. PubMed ID: 16336393
    [Abstract] [Full Text] [Related]

  • 20. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
    Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME.
    Am J Surg; 2008 Aug 01; 196(2):160-9. PubMed ID: 18466862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.